Abstract:Background There have been many studies investigating the impact of the model for end-stage liver disease (MELD) score on predicting post-transplant outcome. But it is unclear whether MELD is correlated to intraoperative fluid therapy and coagulation status. We investigated the relationship between the severity of liver diseases as measured by MELD score and intraoperative fluid requirements and the changes of coagulation characteristics. Methods Ninety patients were included in this retrospective study. The patients were stratified into three groups according to the MELD scores: <15 (low), 15-25 (medium) and >25 (high). Intraoperatively, volume was restored with allogeneic and/or salvaged red blood cells (RBC), fresh-frozen plasma (FFP), platelet and other types of fluids according to hemodynamic data, hematocrit, and clotting data. Intraoperative coagulation data, blood requirements and other fluids administered were compared among the 3 groups. Results Before surgery, in addition to the three variables used to calculate MELD scores in other baseline laboratory values, including ratio of activated partial thromboplastin time (R-APTT), D-Dimer, hematocrit, platelet and blood urea nitrogen (BUN) were significantly different among the 3 groups. The blood loss increased with increasing MELD. The volume of RBC (allogeneinc, salvaged and total), FFP, platelet and the total volume of transfusion were also significantly different among the three groups (P<0.01). The requirements for prothrombin complex and fibrinogen showed a similar pattern. During operation, the changing trends of each coagulation variable were different. Compared with baseline, during each intraoperative stage, INR and R-APPT increased in the low MELD group. While in the medium MELD and high MELD groups, INR did not changed significantly during the operation, and R-APPT significantly increased only after reperfusion. Conclusions This study provided some useful information for perioperative management of patients undergoing liver transplantation. Careful preoperative planning and resource preparation are crucial for patients with high MELD scores. Close communication between surgeon, anesthesiologist and the transfusion staff of blood bank before and during surgery should be stressed.

Relationship between MELD score and the perioperative complications and mortality after orthtopic liver transplantation

The correlation between MELD score and intraoperative blood product, vasopressor requirements and oxygen metabolism in patients undergoing liver transplantation

Potential predictive value of MELD score for mortality after liver transplantation

Timing for liver transplantation for chronic severe hepatitis

Therapeutic Evaluation of the Patients with High MELD Scores Undergoing Liver Transplantation for Benign End-Stage Liver Disease

Model of end stage liver disease (MELD) score greater than 23 predicts length of stay in the ICU but not mortality in liver transplant recipients

Analysis of risk factors of early mortality after liver re-transplantation

Impact of Pretransplant MELD Score on Posttransplant Outcome in Orthotopic Liver Transplantation for Patients with Acute-on-chronic Hepatitis B Liver Failure.

Fluids Administration and Coagulation Characteristics in Patients with Different Model for End-Stage Liver Disease Scores Undergoing Orthotopic Liver Transplantation

Model for end-stage liver disease score in predicting acute kidney injury and prognosis in patients receiving liver transplantation

The contribution of perioperative prognosis evaluation of patients underwent living donor liver transplantation with Acute Physiology and Chronic Health Evaluation Ⅱ models and MELD

Predicting value of preoperative liver function evaluation for prognosis of liver transplantation for hepatocellular carcinoma

MELD Score in the Prediction of Perioperative Risks in Patients Who Underwent Partial Hepatectomy for Hepatocellular Carcinoma

Does Model for End-Stage Liver Disease Score Predict the Short-Term Outcome of Living Donor Liver Transplantation?

Postoperative, but Not Preoperative, MELD-3.0 Prognosticates 3-Month Procedural Success in Patients Undergoing Orthotopic Heart Transplantation

Risk factors for in-hospital mortality of patients with high model for end-stage liver disease scores following living donor liver transplantation.

Predicting short-term survival after liver transplantation on eight score systems: a national report from China Liver Transplant Registry

The risk factor for death related to surgery of recipients subject to liver re-transplantation: A report of 84 cases

Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients

MELD Score and Blood Product Requirements During Liver Transplantation: No Link

Outcomes of Hemi- Versus Whole Liver Transplantation in Patients from Mainland China with High Model for End-Stage Liver Disease Scores: a Matched Analysis